MapLight Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating income | −$82.9M | −$169.1M |
| Net income | −$77.6M | −$161.2M |
| Operating cash flow | −$78.8M | −$138.1M |
| Free cash flow | −$79.6M | −$138.6M |
| Cash | $38.3M | $46.7M |
| Shares outstanding | 761.3K | 44.0M |